---
title: "Raily Aesthetic Medicine Delays Utilization of Proceeds Amid COVID-19 Challenges"
type: "News"
locale: "zh-CN"
url: "https://longbridge.com/zh-CN/news/260581323.md"
description: "Raily Aesthetic Medicine International Holdings Limited (HK:2135) has announced a delay in utilizing HK$8.6 million for organic growth due to difficulties in finding suitable locations in Shanghai amid COVID-19. Additionally, HK$7.6 million from a Rights Issue remains unutilized as the company prepares for product registration. The funds are expected to be used by the end of 2025 and March 2026, respectively. The company focuses on expanding its aesthetic medical services in China and will keep stakeholders updated on progress."
datetime: "2025-10-10T08:41:05.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/260581323.md)
  - [en](https://longbridge.com/en/news/260581323.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/260581323.md)
---

> 支持的语言: [English](https://longbridge.com/en/news/260581323.md) | [繁體中文](https://longbridge.com/zh-HK/news/260581323.md)


# Raily Aesthetic Medicine Delays Utilization of Proceeds Amid COVID-19 Challenges

Raily Aesthetic Medicine International Holdings Limited ( (HK:2135) ) has provided an update.

Raily Aesthetic Medicine International Holdings Limited announced a delay in utilizing HK$8.6 million of its proceeds intended for organic growth due to challenges in identifying suitable locations in Shanghai during the COVID-19 pandemic. Additionally, HK$7.6 million from the Rights Issue remains unutilized as the company prepares for the registration of aesthetic medical equipment products. The company plans to use these funds by the end of 2025 and March 2026, respectively, and will keep stakeholders informed of any progress.

**More about Raily Aesthetic Medicine International Holdings Limited**

Raily Aesthetic Medicine International Holdings Limited operates in the aesthetic medicine industry, focusing on providing aesthetic medical services and products. The company aims to expand its presence in China, particularly through establishing aesthetic medical institutions and registering medical equipment products.

**Average Trading Volume:** 530,727

**Technical Sentiment Signal:** Sell

**Current Market Cap:** HK$64.62M

Find detailed analytics on 2135 stock on TipRanks’ Stock Analysis page.

### 相关股票

- [CHCASTSON81 RTS (02930.HK)](https://longbridge.com/zh-CN/quote/02930.HK.md)
- [RAILY AESMED (02135.HK)](https://longbridge.com/zh-CN/quote/02135.HK.md)

## 相关资讯与研究

- [Raily Aesthetic Medicine Forecasts Turnaround to Profit in 2025](https://longbridge.com/zh-CN/news/277781927.md)
- [Raily Aesthetic Medicine International Holdings Announces Minority Share Subscription in Target Company](https://longbridge.com/zh-CN/news/271664087.md)
- [08:54 ETSnuggle Me® Organic Launches the Infant Rocker After Rapid Limited-Edition Sellout](https://longbridge.com/zh-CN/news/279269761.md)
- [02:20 ETLAKE Investors Have Opportunity to Lead Lakeland Industries, Inc. Securities Fraud Lawsuit](https://longbridge.com/zh-CN/news/279211138.md)
- [16:22 ETFBRT Investors Have Opportunity to Lead Franklin BSP Realty Trust, Inc. Securities Fraud Lawsuit First Filed by the Rosen Law Firm](https://longbridge.com/zh-CN/news/279665849.md)